Literature DB >> 19846886

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization.

Michel Jourdan1, Anouk Caraux, John De Vos, Geneviève Fiol, Marion Larroque, Chantal Cognot, Caroline Bret, Christophe Duperray, Dirk Hose, Bernard Klein.   

Abstract

Human plasma cells (PCs) and their precursors play an essential role in humoral immune response but are rare and difficult to harvest. We report the generation of human syndecan-1(+) and immunoglobulin secreting PCs starting from memory B cells in a 3-step and 10-day (D) culture, including a 6-fold cell amplification. We report the detailed phenotypic and Affymetrix gene expression profiles of these in vitro PCs as well as of intermediate cells (activated B cells and plasmablasts) compared with memory B cells and bone marrow PCs, which is accessible through an open web ATLAS (http://amazonia.transcriptome.eu/). We show this B cell-to-PC differentiation to involve IRF4 and AICDA expressions in D4 activated B cells, decrease of PAX5 and BCL6 expressions, and increase in PRDM1 and XBP1 expressions in D7 plasmablasts and D10 PCs. It involves down-regulation of genes controlled by Pax5 and induction of genes controlled by Blimp-1 and XBP1 (unfold protein response). The detailed phenotype of D10 PCs resembles that of peripheral blood PCs detected after immunization of healthy donors. This in vitro model will facilitate further studies in PC biology. It will likewise be helpful to study PC dyscrasias, including multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846886      PMCID: PMC2834398          DOI: 10.1182/blood-2009-07-235960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

Review 1.  The who, how and where of antigen presentation to B cells.

Authors:  Facundo D Batista; Naomi E Harwood
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 2.  Plasma cell differentiation and survival.

Authors:  David Tarlinton; Andreas Radbruch; Falk Hiepe; Thomas Dörner
Journal:  Curr Opin Immunol       Date:  2008-05-02       Impact factor: 7.486

3.  A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

Authors:  Masumichi Saito; Jie Gao; Katia Basso; Yukiko Kitagawa; Paula M Smith; Govind Bhagat; Alessandra Pernis; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

4.  Higher maturity and connective tissue association distinguish resident from recently generated human tonsil plasma cells.

Authors:  Francisco Medina; Carmen Segundo; Gema Jiménez-Gómez; Inés González-García; Antonio Campos-Caro; José A Brieva
Journal:  J Leukoc Biol       Date:  2007-09-07       Impact factor: 4.962

5.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses.

Authors:  Henrik E Mei; Taketoshi Yoshida; Wondossen Sime; Falk Hiepe; Kathi Thiele; Rudolf A Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

6.  STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

Authors:  Sean A Diehl; Heike Schmidlin; Maho Nagasawa; Simon D van Haren; Mark J Kwakkenbos; Etsuko Yasuda; Tim Beaumont; Ferenc A Scheeren; Hergen Spits
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies.

Authors:  Inés González-García; Beatriz Rodríguez-Bayona; Francisco Mora-López; Antonio Campos-Caro; José A Brieva
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

8.  APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.

Authors:  Bertrand Huard; Thomas McKee; Carine Bosshard; Stéphane Durual; Thomas Matthes; Samir Myit; Olivier Donze; Christophe Frossard; Carlo Chizzolini; Christiane Favre; Rudolf Zubler; Jean Philippe Guyot; Pascal Schneider; Eddy Roosnek
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 9.  Activation-dependent induction of Blimp-1.

Authors:  Kathryn Calame
Journal:  Curr Opin Immunol       Date:  2008-06-12       Impact factor: 7.486

10.  A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.

Authors:  Thierry Rème; Dirk Hose; John De Vos; Aurélien Vassal; Pierre-Olivier Poulain; Véronique Pantesco; Hartmut Goldschmidt; Bernard Klein
Journal:  BMC Bioinformatics       Date:  2008-01-11       Impact factor: 3.169

View more
  112 in total

1.  Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection.

Authors:  Anouk Caraux; Martin Perez-Andres; Marion Larroque; Guilhem Requirand; Zhao-Yang Lu; Tarik Kanouni; Jean F Rossi; Alberto Orfao; Bernard Klein
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Authors:  Arna Katewa; Yugang Wang; Jason A Hackney; Tao Huang; Eric Suto; Nandhini Ramamoorthi; Cary D Austin; Meire Bremer; Jacob Zhi Chen; James J Crawford; Kevin S Currie; Peter Blomgren; Jason DeVoss; Julie A DiPaolo; Jonathan Hau; Adam Johnson; Justin Lesch; Laura E DeForge; Zhonghua Lin; Marya Liimatta; Joseph W Lubach; Sami McVay; Zora Modrusan; Allen Nguyen; Chungkee Poon; Jianyong Wang; Lichuan Liu; Wyne P Lee; Harvey Wong; Wendy B Young; Michael J Townsend; Karin Reif
Journal:  JCI Insight       Date:  2017-04-06

3.  Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration.

Authors:  Jerome Moreaux; Dirk Hose; Alboukadel Kassambara; Thierry Reme; Philippe Moine; Guilhem Requirand; Hartmut Goldschmidt; Bernard Klein
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

Review 4.  The unique features of follicular T cell subsets.

Authors:  Julie Tellier; Stephen L Nutt
Journal:  Cell Mol Life Sci       Date:  2013-07-14       Impact factor: 9.261

5.  Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.

Authors:  Michelle M McDonald; Michaela R Reagan; Scott E Youlten; Sindhu T Mohanty; Anja Seckinger; Rachael L Terry; Jessica A Pettitt; Marija K Simic; Tegan L Cheng; Alyson Morse; Lawrence M T Le; David Abi-Hanna; Ina Kramer; Carolyne Falank; Heather Fairfield; Irene M Ghobrial; Paul A Baldock; David G Little; Michaela Kneissel; Karin Vanderkerken; J H Duncan Bassett; Graham R Williams; Babatunde O Oyajobi; Dirk Hose; Tri G Phan; Peter I Croucher
Journal:  Blood       Date:  2017-05-17       Impact factor: 22.113

6.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

9.  Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma.

Authors:  Matthieu Schoenhals; Alboukadel Kassambara; Jean-Luc Veyrune; Jerome Moreaux; Hartmut Goldschmidt; Dirk Hose; Bernard Klein
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

10.  B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.

Authors:  Matthieu Mahévas; Pauline Patin; François Huetz; Marc Descatoire; Nicolas Cagnard; Christine Bole-Feysot; Simon Le Gallou; Mehdi Khellaf; Olivier Fain; David Boutboul; Lionel Galicier; Mikael Ebbo; Olivier Lambotte; Mohamed Hamidou; Philippe Bierling; Bertrand Godeau; Marc Michel; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.